KEY POINTS
  • CNBC's Jim Cramer calculates how health-focused conglomerate Danaher could still get its groove back.
  • The "Mad Money" host also sits down with the CEO of Centene, who talks Obamacare.
  • In the lightning round, Cramer gets fed up with the stock of Scotts Miracle-Gro.

Every once in a while, CNBC's watches a once-beloved stock fall out of favor with investors. But what really interests him is how that stock gets its groove back when Wall Street throws it to the wayside.

"Let’s consider the case of Danaher, the life sciences, diagnostics and environmental technology play," the "Mad Money" host said on Tuesday. "Over the past few decades — decades — Danaher has been perhaps the single best conglomerate on earth."